Journal list Promote Sponsor
verified SJR 1,025 · Q2 • database Scopus / SJR & DOAJ indexed
Clinical and Molecular Allergy
United Kingdom · BioMed Central Ltd
workspace_premium Q2 — Molecular Biology verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Clinical and Molecular Allergy

Clinical and Molecular Allergy is a journal indexed in SJR in Molecular Biology and Immunology with an H index of 45. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 1890 €. The scope of the journal is focused on allergic diseases, molecular allergy, allergens. It has an SJR impact factor of 1,025 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1,025.

Publisher: BioMed Central Ltd
Category: Molecular Biology
Indexation: verifiedScopus / SJR verifiedDOAJ
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
1,025 Q2
H-index 45
Acceptance rate pie_chart
33%
Source Acceptance_Rate
Time to publication hourglass_top
13 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
1.890 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR DOAJ

SJR Impact

1,025

H-index

45

Docs (year)

1

Docs 3y

50

Total refs

1

Cites 3y

145

Citable 3y

41

Cites/Doc 2y

3.52

Ref/Doc

1.0

Immediate OA

1890 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs